Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 7 days
interactive investor19:11 1-Nov-24
Motley Fool (UK)23:05 30-Oct-24
GlaxoSmithKline (Press Release)18:18 30-Oct-24
Proactive Investors (UK)02:50 30-Oct-24
FiercePharma01:54 31-Oct-24
FierceBiotech22:39 30-Oct-24
City AM18:33 30-Oct-24
In the last 14 days
Financial Mail15:27 27-Oct-24
Motley Fool (UK)21:50 25-Oct-24
Scrip Pharma Intelligence16:50 26-Oct-24
FiercePharma01:41 25-Oct-24
Seeking Alpha10:04 25-Oct-24
FiercePharma07:15 25-Oct-24
Seeking Alpha08:28 23-Oct-24
Proactive Investors (UK)21:05 25-Oct-24
FiercePharma02:18 24-Oct-24
Business Weekly18:56 22-Oct-24
Varsity00:45 26-Oct-24
Proactive Investors (UK)21:15 25-Oct-24
The Avondhu13:03 26-Oct-24
Pharmaceutical Technology02:50 26-Oct-24
pharmaphorum22:19 25-Oct-24
London South East19:29 24-Oct-24
GlaxoSmithKline (Press Release)17:10 24-Oct-24
Pharmaceutical Technology19:02 22-Oct-24
Manufacturing Chemist20:54 28-Oct-24
ENDPOINTS21:07 25-Oct-24
JD Supra08:21 25-Oct-24
TipRanks17:17 24-Oct-24
American Journal of Managed Care03:20 24-Oct-24
Express & Star16:05 22-Oct-24
Benzinga07:10 25-Oct-24

GlaxoSmithKline News

Â鶹´«Ã½ aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.